With a current price of $2.50, ADMA Biologics Inc. [NASDAQ:ADMA] is active in the Biotechnology industry, with a 5-day price swing of 12.11%.
For the year, the stock is trading -37.50%, while, as a point of reference, the S&P 500 is trading 0.5% YTD. Other data to note on this name is a price per sales number of 5.21.
Holding a Market Cap of $193.78 million, ADMA Biologics Inc. has seen a trading range over the last year of $1.45-$5.25.
For the last five days, ADMA is up from its last closing price. The average shares trading hands each day is 6.33M, with average 10-day volume coming in at 5.8 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for ADMA. When we apply the Elder Force Index to ADMA Biologics Inc., we are seeing an Elder Force Indicator number of 0.0.
The company’s enterprise value has gone from $249.91M to $306.65M quarter-over-quarter. This could be an inflection point for the company, but either way we believe you should be adding them to your watchlist.
In the last quarter, ADMA made a profit of -5.71 million. ADMA Biologics Inc. also saw quarter revenue growth year over year of 72.79%. In addition, the company has operating cash flow of -$89.21 million.
Looking at popular technical indicators, the company’s 5-day moving average is 2.49 compared to the 50-day moving average of 2.4010. So, we are clearly seeing an upward trajectory here.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. ADMA currently holds a 9-day RSI of 57.74%, while 100-day RSI stands at 47.76%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. ADMA’s 9-day MACD is 0.10 and the company’s 100-day MACD stands at -0.26.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 7.35% by insiders and 47.91% by institutions. Regarding institutional holdings, Perceptive Advisors Llc owns 19.21%, while the second top holder, Blackrock Inc., currently owns 6.63%.
Over the last six months, insiders have bought 2,200 with the most recent transaction from DEMSKI MARTHA J, Director, with a purchase at price 2.29 per share.
Overall, the recommended rating for ADMA is Strong Buy. Currently, the company has 5 analysts watching the stock, and the average quarterly earnings estimate is -0.2. Quarterly revenue estimates are averaging 9.81M with the high estimate reaching 10.9M and the low at 9.27M.